KELOMPOK KONTROL

KODE KADAR TERAPI PENYAKIT PENYERTA MEROKOK OLAHRAGA

L/P USIA BMI
SAMPLE P1NP INSULIN OAD HTN DISLIPIDEMIA LAIN2
K1 P 59 24.46 106,150 Metformin, acarbose,
- + + - - -
gliquidone
K2 P 46 23.05 1,428,140 + Metformin HHD + katarak - -
K3 L 47 20.86 95,977 + - + - - - -
K4 P 40 24.61 92,595 Metformin, acarbose,
- - + - - -
glibenclamide
K5 L 64 27.55 136,920 + Acarbose + - - - -
K6 L 44 22.58 322,824 + - - - - - -
K7 L 47 22.68 213,805 - Metformin, gliclazide - - - - -
K8 L 59 29.07 154,182 Metformin,
- + - CHF - -
gliquidone, acarbose
K9 L 47 25.59 425,608 berhenti 2 th
+ Metformin - + Dyspepsia -
yll
K11 L 59 25.71 89,218 + - + + - - -
K12 L 53 20.40 210,255 + - - + - - -
K13 L 54 24.77 282,255 - Metformin, gliclazide HHD + - - -
K14 L 64 23.05 168,079 - Metformin + + OMI - -
K15 L 66 23.56 989,730 - Glimepiride + - Katarak - -
K16 L 65 22.89 196,115 Glibenclamide,
- + + - - -
gliquidone
K17 L 49 22.77 410,077 + - + + Vertigo - -
K18 L 66 25.28 1,016,252 Chronic berhenti 1 bln
- Metformin + - -
periodontitis yll
K19 L 64 21.67 224,481 Metformin, acarbose,
- + + - berhenti 2001 -
gliquidone
K20 L 68 24.77 1,935,194 - Gliclazide, acarbose + + - - -
K21 L 67 24.77 1,162,025 - Metformin, gliclazide + + - - -
K22 L 63 22.66 143,810 - Gliquidone, acarbose - - Hiperurisemia - -
K23 P 51 26.22 116,364 + - - + - - -
K24 L 47 24.01 220,917 + Metformin + + Ulkus pedis - -
K25 L 67 23.88 228,051 + - - + - - -
K26 L 51 25.71 2,002,207 + Metformin + + - - -
K27 L 68 24.17 171,566 + Metformin, + + - - -
 gliquidone

PIOGLITAZONE

KODE KADAR TERAPI PENYAKIT PENYERTA

L/P USIA BMI MERK DURASI MEROKOK OLAHRAGA
SAMPLE P1NP INSULIN OAD HTN DISLIPID LAIN2
PIO 18 Metformin,
P1 L 62 23.88 189,075 - + - - - -
generik bulan gliclazide
PIO 14 Katarak +
P2 L 67 27.58 164,597 - Gliquidone - + - -
generik bulan Hiperurisemia
PIO
P3 P 51 24.03 6 bulan 231,628 + Metformin + + Dyspepsia - -
generik
PIO 19
P4 P 41 22.89 196,115 + Gliquidone - + - - -
generik bulan
PIO 10
P5 L 58 26.03 300,607 - Glimepiride + - - - -
generik bulan
PIO
Metformin,
generik 19
P6 P 51 22.66 161,120 - Gliclazide, + + - - -
+ bulan
Acarbose
Deculin
PIO 19 Metformin,
P7 L 64 24.32 704,573 - + + Katarak - -
generik bulan Gliclazide
Pio
generik
P8 L 64 22.10 7 bulan 394,654 - Metformin + + HF - -
+
Deculin
Pio
generik 18
P9 L 63 23.88 296,925 + - - + Hiperurisemia - -
+ bulan
Deculin
Pio Metformin,
P10 L 65 24.54 9 bulan 196,115 - + + PJK OMI - -
generik Glimepiride
Pio
P11 L 68 23.74 8 bulan 164,597 + Gliquidone - - - + -
generik
Pio 15
P12 L 63 21.83 164,597 - - + - - - +
generik bulan
Pio 19 Metformin,
P13 P 44 26.90 249,583 + - - - - -
generik bulan Glimepiride
 Pio
P14 L 39 22.66 5 bulan 445,180 - Metformin - - - + -
generik
Pio
generik
P15 L 58 21.99 8 bulan 989,730 - Gliclazide - - - - -
+
Deculin
Pio Metformin,
P16 L 45 24.80 6 bulan 157,649 + + - - - -
generik Acarbose
Pio
P17 L 68 22.96 4 bulan 182,056 - Metformin - + - - -
generik
Pio Metformin ,
P18 L 59 23.23 4 bulan 341,506 - + - - - -
generik Gliclazide
Pio Metformin ,
P19 L 63 19.27 9 bulan * - - + Katarak - -
generik Gliclazide
Pio 19
P20 P 52 21.48 210,256 - Glimepiride + + Hiperurisemia - -
generik bulan
Pio
P21 P 42 23.92 4 bulan 164,597 - Metformin - - Hiperurisemia - -
generik
Pio 20 Metformin,
P22 P 50 26.12 206,713 - + + - - -
generik bulan Glibenclamide
Pio
P23 L 65 24.61 7 bulan 282,255 - Gliclazide + - - - -
generik
Pio 19
P24 L 62 27.18 595,938 + Gliquidone + + - - -
generik bulan
Pio 18
P25 L 68 22.66 217,358 + Metformin + + - - -
generik bulan
Pio
P26 L 58 24.24 7 bulan 249,583 + Metformin - + Hiperurisemia - +
generik